what is enterobiasis
how is Enterobiasis transmitted
Pinworm infection is most common in what population
5-14 y/o
*most common intestinal parasite in primary care regardless of socioeconomic circumstances
where is enterobiasis most prevalent
-
what are the usual consequences of infection
loss of sleep, discomfort due to anal itching and embarrassment do to social connotations of having “worms.”
*often entire family is infected
goals of therapy for pinworm treatment
Eliminate the infection
Relieve symptoms such as itchiness
Promote good hygiene
Prevent transmission, reinfection and complications
how to assess for pinworms
*rule out diaper dermatitis, constipation, psoriasis of the anogenital region, and perianal eczema before recommending pinworm treatment
what can extnesive pinwro infection cause
abdominal pain, nausea and vomiting -> not typical of uncomplicated infection
* If abdominal pain, severe diarrhea, bloody bowel movements, dysuria, fever, extreme poor appetite, neurotic excoriation (self-inflicted lesions produced by repetitive scratching) or anogenital symptoms associated with sexual abuse
REFER
how is pinworm diagnosis confirmed
most common diagnostic methods are
prevention of pinworms
difficult.
proper hygiene is helpful and includes careful handwashing after going to the toilet, after scratching the perianal area, and before and after eating or preparing food
is pinworm self limiting
non pharm measures for pinworm
when is pharmacologic therapy used
non prescription treatment for pinworms
pyrantel pemoate
prescription treatment for pinworms
mebendazole
what treatment is only avialable through Health Canada’s Special Access Program (SAP)
cases of pinworms during pregnancy
*Do not use mebensazole - maybe in 2nd or 3rd trimester
pryantel pamoate: insufficient info
albendazole: some reports suggesting not a major human teratogen, shown not of major risk during first trimester
pinworm treatment while breastfeeding
Pyrantel pamoate: limted into in breastfeeding, but its poorly absorbed orally do considered compatible
Albendazole: metbaolized into active, its minimally transferred itno breast milk and poorly absorbed from GI -> minimal risk from a single oral dose treatment
minitoring: perianal itching
HC provider: day 7
monioring for N/V/D and abdominal cramps
parent/patient: monitor daily
HC practitioner: day 1 after treatment
monitoring: dizziness and drowsiness
parent/patient: monitor daily
HC practitioner: da 1 after treatment